Ongoing product recalls, warning letters, and questions about the revisions to the European Union s GMP Annex 1, present challenges and opportunities in aseptic drug manufacturing. In a keynote session at INTERPHEX 2019, experts will review and debate the issues, and present potential solutions.Original Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.